MASS 908 Devices Inc.
Updated
Healthcare · Laboratory Analytical Instruments
908 Devices Inc. (MASS) is a healthcare company in the Laboratory Analytical Instruments industry, with a market capitalization of $414 million. Shares last traded at $10.02, 10.4% below their 52-week high. Over the past year the stock is up 82.2%. Net profit margin is -57.0%, below the peer median of -1.7%. Revenue grew 17.7% year over year.
Performance
Chart
Full chart →Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.
Technicals
Financials
Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.
Recent earnings
| Period | EPS (diluted) | Reported |
|---|---|---|
| Q2 2026 | $-0.64 | 2026-08-11 |
| Q1 2026 | $-0.32 | 2026-05-06 |
| FY 2025 | $0.54 | 2026-03-09 |
| Q3 2025 | $0.43 | 2025-11-10 |
| Q2 2026 | $0.85 | 2026-08-11 |
| Q1 2026 | $1.23 | 2026-05-06 |
Laboratory Analytical Instruments peers
MASS vs 14 industry peers (Laboratory Analytical Instruments), by market cap. Updated
| A | Agilent Technologies | $42.3B | 29.35 | 5.73 | 19.5% | -0.93% |
| WAT | Waters Corporation | $40.6B | 63.24 | 8.75 | 13.8% | +0.36% |
| ILMN | Illumina, Inc. | $33.5B | 40.58 | 7.45 | 18.4% | +3.90% |
| MTD | Mettler Toledo | $27.2B | 30.01 | 6.58 | 21.9% | -0.77% |
| RVTY | Revvity | $14.6B | 61.37 | 5.01 | 8.2% | -0.24% |
| BIO | Bio-Rad Laboratories, Inc. | $10.4B | 46.81 | 4.02 | 8.6% | -0.19% |
| AVTR | Avantor, Inc. | $10.4B | -18.81 | 1.58 | -8.4% | +3.65% |
| BRKR | Bruker Corp | $9.1B | -127.12 | 2.59 | -2.0% | +0.61% |
| TXG | 10x Genomics, Inc. | $8.2B | -108.50 | 13.21 | -12.2% | +2.45% |
| ALMR | Alamar Biosciences, Inc. | $2.1B | — | — | — | +0.51% |
| CTKB | Cytek Biosciences, Inc. | $611M | -9.18 | 2.96 | -32.2% | +0.21% |
| MASS | 908 Devices Inc. | $414M | -11.95 | 6.81 | -57.0% | -3.05% |
| PACB | Pacific Biosciences Of California, Inc. | $403M | -3.06 | — | — | -1.52% |
| EYPT | Eyepoint, Inc. | $394M | -1.28 | — | — | -4.39% |
Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.